COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort studyJérôme Avouac, Pierre Barbery, Édouard Pertuiset et al.|The Lancet Rheumatology|2021Cited by 292
Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 studyDominique Farge, Karin Tarte, Séverine Loisel et al.|The Lancet Rheumatology|2022Cited by 38
French protocol for the diagnosis and management of hematopoietic stem cell transplantation in autoimmune diseasesDominique Farge, Zora Marjanovic, G. Pugnet et al.|La Revue de Médecine Interne|2024Cited by 9